• Save

Zydus receives final approval from the USFDA for Chlorthalidone Tablets USP

NEWS

Zydus Cadila has received the final approval from the USFDA to market Chlorthalidone TabletsUSP (US RLD – THALITONE@),25 mg and 50 mg. Chlorthalidone is usedto treat high blood pressure(hypertension). It is also used to treat fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver or kidney disorders or edema caused by taking steroids or estrogen. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. #Zydus #Cadila

Zydus receives final approval from the USFDA for Chlorthalidone Tablets USP
  • Save

The group now has 266 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04. Read More

0 Shares
Market King

I am a investor and Technical analysis.

Leave a Reply